Needle-Free Monitoring for IVF Patient Cycles
| Status: | Recruiting |
|---|---|
| Conditions: | Women's Studies, Infertility |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 25 - 43 |
| Updated: | 5/5/2018 |
| Start Date: | May 9, 2017 |
| End Date: | June 2019 |
| Contact: | Kristin Rooney, BA |
| Email: | krooney@bostonivf.com |
| Phone: | 781-434-6500 |
Venopuncture-Free Monitoring During IVF: Are More Frequent Sequential Salivary Hormone Measurements More Informative Than Daily Serum Monitoring of IVF Patients?
Salivary diagnostic testing is emerging as a less invasive, inexpensive alternative to serum
analyte measurements with proven diagnostic accuracy in clinical settings. This study aims to
continue analyzing aspects of the performance of salivary hormone competitive immunoassays
for monitoring patient's reproductive hormone profiles in the reproductive cycle. Hormone
levels will be monitored during treatment cycles for infertility.
analyte measurements with proven diagnostic accuracy in clinical settings. This study aims to
continue analyzing aspects of the performance of salivary hormone competitive immunoassays
for monitoring patient's reproductive hormone profiles in the reproductive cycle. Hormone
levels will be monitored during treatment cycles for infertility.
This study will be a prospective study to measure salivary and serum estrogen and
progesterone levels in subject's voluntarily undergoing monitored infertility treatment
cycles including controlled ovarian stimulation (COS) with oral agents or gonadotropins and
controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). Ultimately, the
potential applicability and reliability of salivary steroid monitoring in IVF cycles will be
assessed.
progesterone levels in subject's voluntarily undergoing monitored infertility treatment
cycles including controlled ovarian stimulation (COS) with oral agents or gonadotropins and
controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). Ultimately, the
potential applicability and reliability of salivary steroid monitoring in IVF cycles will be
assessed.
Inclusion Criteria:
- Diagnosis of infertility.
- Cycle start age of 25 -43 years.
- Undergoing controlled ovarian stimulation for IVF.
- All monitoring scheduled at the participating IVF facility.
Exclusion Criteria:
-Prior cancelled cycle due to hyperstimulation.
We found this trial at
1
site
Waltham, Massachusetts 02451
Principal Investigator: Denny Sakkas, PhD
Phone: 781-434-6500
Click here to add this to my saved trials
